Used primarily in the treatment of osteoporosis, particularly in postmenopausal women, men with primary or hypogonadal osteoporosis at high risk of fracture, and patients at high risk receiving long-term glucocorticoid therapy. It works by stimulating bone formation, increasing bone mineral density, and reducing the risk of fractures. It is also employed in cases where other osteoporosis treatments have failed or are not suitable. Additionally, it is used for the management of hypoparathyroidism, helping to regulate calcium and phosphate levels in the blood. Administered via subcutaneous injection, it is typically prescribed for a limited duration due to potential long-term risks.